Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ACTRN12625000700437) titled 'Medium chain triglyceride (MCT) supplementation in rural aged care residents: Phase 2a clinical trial' on July 1.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Other
Type of endpoint: Safety/efficacy
Primary Sponsor: Riverland Mallee Coorong Local Health Network
Condition:
cognitive impairment
Alzheimers disease
cognitive impairment
Alzheimers disease
Neurological - Alzheimer's disease
Neurological - Dementias
Intervention:
The step-wedge trial will cover 3 phases over a 22-week period. The following phases incl...